![]() |
||
| Home | Firm Description | Sectors Covered | Completed Transactions | Testimonials | Principals | M&A Report and Publications |
Contact Us |
| Acquiring Party | AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of medical devices for the diagnosis and treatment of peripheral vascular diseases and other non-coronary diseases. |
|---|---|
| Transferring Party | RITA Medical Systems, Inc. (NASDAQ:RITA, a provider of vascular access ports, RF tumor ablation products and other medical oncology devices. |
| Sector | Medical Devices |
| Date | November 28, 2006 |
| Analysis Creates a diversified producer of access, diagnostic and therapeutic products that enable interventional physicians and surgeons to treat peripheral vascular diseases and cancerous tumors. RITA's 33-person U.S. sales force targets the same customer base as does AngioDynamics' 52-person U.S. sales force; companies have virtually no product overlap. Deal price -- $220m plus $3.3 in assumed debt. Combined revenue exceeds $132m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |